(Press-News.org) PHILADELPHIA — Deciding the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy could be guided by certain analyses of cancer cells isolated from the patients' blood, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.
"The growth and survival of prostate cancer cells are very dependent on signals that the cancer cells receive through a protein called the androgen receptor," said Daniel A. Haber, M.D., Ph.D., director of the Massachusetts General Hospital Cancer Center in Boston and project leader of the Stand Up To Cancer Bioengineering and Clinical Applications of Circulating Tumor Cell Chip Dream Team. "Treatments that deprive the androgen receptor of its signals are initially highly effective in most patients with metastatic prostate cancer. Unfortunately, prostate cancer, like all cancers, undergoes evolution during therapy, and this can confer resistance to treatment."
Haber and his colleagues established a way to isolate cancer cells from the blood of patients with prostate cancer and to measure readouts of androgen receptor signaling in each of the individual cancer cells in the blood.
Prior to the initiation of androgen-deprivation therapy, the androgen receptor signaling pathway was turned on in most of the cancer cells in the blood of patients with newly diagnosed metastatic prostate cancer. After the initiation of androgen-deprivation therapy, the pathway turned off in the circulating tumor cells.
However, in patients whose prostate cancer had progressed after initially responding to androgen-deprivation therapy, the cancer cells in the blood were highly variable. Some cells had the androgen receptor signaling pathway turned on while other cells had it turned off. Yet other cells had characteristics of the signaling pathway being both on and off. The presence of cells with a mixed androgen receptor signaling pattern was associated with an adverse treatment outcome.
In addition, in patients treated with a new drug, abiraterone, which achieves more complete androgen deprivation than earlier treatments, an increased percentage of circulating tumor cells with androgen receptor signaling turned on despite abiraterone treatment was associated with decreased overall survival.
"This study is a proof of principle that it is possible to monitor, in patients with metastatic prostate cancer, the androgen receptor signaling pathway in real time, repeatedly and noninvasively," Haber said. "Our approach allowed us to monitor whether initial androgen-deprivation therapy was keeping the androgen signaling pathway shut down or whether the tumor was becoming resistant, and if so, by what mechanism."
"As more drugs are developed that target the different pathways that drive the recurrence of metastatic prostate cancer in different patients, it will become essential to know which drug and which pathway is relevant in each patient," he said. "Our assay will be an effective way to interrogate the tumor and follow it during the course of treatment to monitor therapy response and the emergence of drug resistance."
###
This work was supported by the Evans Foundation, the Prostate Cancer Foundation and Stand Up To Cancer.
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
Noninvasive assay monitored treatment response in patients with metastatic prostate cancer
2012-10-23
ELSE PRESS RELEASES FROM THIS DATE:
Simple, inexpensive risk score can shorten length of stay for MI patients
2012-10-23
MINNEAPOLIS, MN—October 23, 2012—A simple-to-use risk score can identify low-risk patients following a severe heart attack (STEMI) and may provide an opportunity to employ early discharge strategies to reduce length of hospital stay and save hospital costs without compromising the safety of the patient, based on a study presented by the Minneapolis Heart Institute Foundation on Oct. 23 at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference.
Recently, there has been an emphasis on lowering both hospital length of stay and hospital readmission in patients ...
Prior cardiac surgery does not mean worse outcomes for STEMI patients who receive stent
2012-10-23
MINNEAPOLIS, MN—October 23, 2012—Contrary to previous data, patients with prior open heart surgery, or coronary artery bypass graft surgery (CABG), who have a severe heart attack (STEMI) and receive a coronary stent have similar outcomes to patients without previous CABG, based on study of a large, prospective, regional STEMI network, being presented Oct. 23 at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference.
Recognizing that the majority of data indicating worse outcomes for STEMI patients with prior CABG came from an older era of heart attack treatment, ...
EARTH: Earthquake? Blame it on the rain
2012-10-23
Alexandria, VA – The U.S. Geological Survey's website states it in no uncertain terms: "There is no such thing as 'earthquake weather.'" Yet, from at least the time of Aristotle, some people have professed links between atmospheric conditions and seismic shaking. For the most part, these hypotheses have not held up under scientific scrutiny and earthquake researchers have set them aside as intriguing but unfounded ideas. However, in the last decade new efforts to identify effects of weather-related, or in some cases climate-related, processes on seismicity have drawn new ...
Study shows New Jersey's decal for young drivers reduced crashes
2012-10-23
Philadelphia, October 23—A new study shows that New Jersey's law requiring novice drivers to display a red decal on their license plates has prevented more than 1,600 crashes and helped police officers enforce regulations unique to new drivers. The first-in-the-nation decal provision went into effect in May 2010 as part of N.J.'s Graduated Driver Licensing (GDL) law. Nearly every state has a GDL law on the books, but "Kyleigh's Law," named for a teen driver killed in a 2006 N.J. crash, is the first one that requires drivers under age 21 to display their probationary status ...
Effective treatment helps Danes with personality disorders
2012-10-23
For seven years, Carsten René Jørgensen from the Department of Psychology and Behavioural Sciences at Aarhus University has collaborated with the Clinic for Personality Disorders, Aarhus University Hospital, Risskov on examining the extent to which modern psychoanalytic psychotherapy can help the Danes suffering from severe borderline personality disorders.
Among the first to examine these forms of modern psychoanalytic treatment of severe personality disorders, the study shows a clear trend; a vast majority of patients do better after a two-year course of treatment.
- ...
Improving medical research education across Europe
2012-10-23
Fostering and improving medical research education is crucial to biomedical research and clinical patient treatment, and as such it has been identified as the main challenge in every joint European Science Foundation (ESF) - European Research Medical Councils (EMRC) strategy report. A new policy report entitled "Medical Research Education in Europe" has just been published looking at crucial factors to improve medical research education throughout Europe.
The new science policy briefing report features an overview of medical researchers' training across Europe. It identifies ...
Leading European experts call for more rigorous scientific evidence for healthcare interventions
2012-10-23
Leading clinicians and health researchers from across Europe say much greater emphasis must be placed on the scientific evidence for the effectiveness of treatments and other healthcare interventions to ensure patients receive the best care available. The call is contained in a Science Policy Briefing published by the European Medical Research Councils, which also made ten key recommendations on how to improve the quality of research and healthcare in Europe.
The briefing, 'Implementation of Medical Research in Clinical Practice', says that there must be much greater ...
Biologists record increasing amounts of plastic litter in the Arctic deep sea
2012-10-23
Biologists record increasing amounts of plastic litter in the Arctic deep sea: studies confirm that twice as much marine debris is lying on the seabed today compared to ten years ago
Bremerhaven, 22nd October 2012. The seabed in the Arctic deep sea is increasingly strewn with litter and plastic waste. As reported in the advance online publication of the scientific journal Marine Pollution Bulletin by Dr. Melanie Bergmann, biologist and deep-sea expert at the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association. The quantities of waste observed ...
Next-generation vaccines -- eliminating the use of needles
2012-10-23
Lead scientist Professor Simon Cutting, from the School of Biological Sciences at Royal Holloway, has developed the jabs through the use of probiotic spores. He carried out fundamental studies into the biology of the bacterium Bacillus subtilis which attracted the attention of microbiologists due to its ability to form spores that can last millions of years before germinating under the appropriate environmental conditions.
Professor Cutting says: "The mechanisms by which this process occurs have fascinated microbiologists for decades making it one of the most intensively ...
Turbulent flows in 2D can be calculated in new model
2012-10-23
Turbulent flows have challenged researchers for centuries. It is impossible to predict chaotic weather more than a week in advance. Wind resistance on a plane or a car cannot be calculated precisely, since it is determined by atmospheric turbulence. Now, however, researchers from the Niels Bohr Institute have succeeded in developing a statistical model that can replicate the chaotic flows and thereby provide a better understanding of the process. The research results are published in the scientific journal, Physics of Fluids.
"Without knowing the movements in detail, we ...